-
Drivers of High ICERs in SMC Appraisals
Mar 10, 2025, 14:00 PM -
Hypophosphatasia (HPP) Patient & Caregiver Disease Burden, Quality of Life & Treatment Experience: A Mixed Methods Study Concept
Mar 10, 2025, 14:00 PM -
Landscape Review of Patient Engagement in the Health Technology Assessment (HTA) Process in Latin America
Mar 10, 2025, 14:00 PM -
Unveiling the Impact: Economic and Resource Utilization Analysis of Drug-Resistant Epilepsy Patients in the US
Mar 10, 2025, 14:00 PM -
US Stakeholder Perspectives on Accumulators, Maximizers, and Alternative Funding Programs: Implications for Patient Affordability and Outcomes Research
Mar 10, 2025, 14:00 PM -
Potential Added Clinical Value of Polygenic Risk Scores in Risk Assessment of Atherosclerotic Cardiovascular Disease
Mar 10, 2025, 14:00 PM -
Does a Digital Health Program Influence One’s Choice of Traditional Health Care? Changes in Health Care Use and Episodic Cost Among a Group of Chronic MSK Patients in a Digital Conservative Musculoskeletal Care Program
Mar 10, 2025, 14:00 PM -
Comparing Predicted vs. Real-World Spending in the United States for Single-Administration Cell and Gene Therapies
Mar 10, 2025, 14:00 PM -
Humanistic Burden in Metastatic Triple-Negative Breast Cancer (mTNBC): A Systematic Literature Review (SLR)
Mar 10, 2025, 14:00 PM -
Incorporating Social Drivers of Health Information Into Health Economics and Outcomes Research: Neighborhood-Level Proxies Versus Individual Level Data
Mar 10, 2025, 14:00 PM -
Pressures Behind the Rising Costs in Canadian Private Drug Plans: 2018-2023
Mar 10, 2025, 14:00 PM -
Joint Modeling for Clinical Interpretation of ctDNA Tumor Methylation Dynamics During Longitudinal Monitoring
Mar 10, 2025, 14:00 PM -
Economic Analysis of the Use of Polyhexamethylene Biguanide Associated with Betaine (PHMB) Gel Compared to Silver Sulfadiazine in the Treatment of Second-Degree Burns
Mar 10, 2025, 14:00 PM -
Impact of Polatuzumab Vedotin as First-Line Therapy for DLBCL on Subsequent Treatments: Brazilian Model
Mar 10, 2025, 14:00 PM -
Cost-effectiveness of Chimeric Antigen Receptor (CAR) T-cell Therapy for Relapsed or Refractory Large B-cell Lymphoma (r/r LBCL): A Systematic Review and Meta-Analysis
Mar 10, 2025, 14:00 PM -
Assessing the Impact of Exagamglogene Autotemcel (Exa-cel) on Health Inequalities in Patients with Sickle Cell Disease in the United Kingdom and Canada
Mar 10, 2025, 14:00 PM -
Target Aggregate Data Adjustment Method (TADA): A Solution for Performing Transportability Analysis with Only Aggregate-Level Data in the Target Population
Mar 10, 2025, 14:00 PM -
Analysis of 20 Years of Legislative Trends to Predict Future Investment and Access to Orphan Drugs
Mar 10, 2025, 14:00 PM -
Patient's Experience of Crohn's Disease: A Conceptual Model Based on Qualitative Interviews
Mar 10, 2025, 14:00 PM -
Mapping between the HUI2/HUI3 and the PROPr in the United States
Mar 10, 2025, 14:00 PM
